Trial site
Europejskie Centrum Zdrowia Otwock Sp. Z.o.o.
- 21running trials
- 16closed trials
The trials here
What the 37 trials at this site are about, from their registry records.
- Conditions
- Kidney cancer10 trials
- High blood pressure8 trials
- Pulmonary arterial hypertension7 trials
- Colorectal cancer6 trials
- Prostate cancer6 trials
- Metastatic breast cancer4 trials
- Liver and biliary tract cancer3 trials
- Ovarian cancer3 trials
- Bladder cancer2 trials
- Gastric and oesophageal cancer2 trials
- Lung cancer2 trials
- Pancreatic cancer2 trials
- and 1 more
- Phase
- Phase 326 trials
- Phase 26 trials
- Phase 14 trials
- Phase 41 trial
- Status
- Completed15 trials
- Active, not recruiting11 trials
- Recruiting9 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Exelixis4 trials
- Merck Sharp & Dohme LLC3 trials
- Acceleron Pharma Inc.2 trials
- Astellas Pharma Global Development, Inc.2 trials
- Molecure S.A.2 trials
- and 22 more
Running trials
Recruiting
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Active, not recruiting
Recruiting
Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Recruiting
Active, not recruiting
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Recruiting
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer4 recruiting
- Kidney cancer4 recruiting
- Gastric and oesophageal cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Ovarian cancer2 recruiting
- Pancreatic cancer2 recruiting
- Bladder cancer1 recruiting
- Head and neck cancer1 recruiting
- High blood pressure1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Prostate cancer1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Completed
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Completed
Completed
Completed
Completed
Completed
Completed
A Long-term Follow-up Study of Sotatercept for PAH Treatment
Active, not recruiting
Active, not recruiting
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
Completed
Terminated
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026